Holen Sie sich die Stockscreener-App
230.02
0.71%
-1.65
Vorhandelsmarkt:
228.01
-2.01
-0.87%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LH?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$231.67
Offen:
$231.67
24-Stunden-Volumen:
479.63K
Relative Volume:
0.86
Marktkapitalisierung:
$19.39B
Einnahmen:
$12.71B
Nettoeinkommen (Verlust:
$435.50M
KGV:
44.66
EPS:
5.15
Netto-Cashflow:
$843.20M
1W Leistung:
-1.79%
1M Leistung:
-7.17%
6M Leistung:
+3.57%
1J Leistung:
+5.29%
1-Tages-Spanne:
$228.71
$233.45
1-Wochen-Bereich:
$228.71
$240.12
52-Wochen-Spanne:
$191.97
$258.59
Labcorp Holdings Inc Stock (LH) Company Profile
Firmenname
Labcorp Holdings Inc
Sektor
Branche
Telefon
(336) 229-1127
Adresse
358 S MAIN ST, BURLINGTON, NC
Vergleichen Sie LH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
230.02 | 19.39B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
500.16 | 196.14B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
205.85 | 150.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
IDXX
Idexx Laboratories Inc
|
415.87 | 34.36B | 3.90B | 887.87M | 798.08M | 10.67 |
|
A
Agilent Technologies Inc
|
116.69 | 33.28B | 6.53B | 1.26B | 1.31B | 4.35 |
|
IQV
Iqvia Holdings Inc
|
177.39 | 31.62B | 15.41B | 1.37B | 2.11B | 7.50 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-01-07 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2024-12-10 | Fortgesetzt | Jefferies | Buy |
| 2024-10-30 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-10-01 | Eingeleitet | Piper Sandler | Neutral |
| 2024-03-25 | Hochstufung | Argus | Hold → Buy |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2024-02-09 | Eingeleitet | Evercore ISI | In-line |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2022-12-12 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-09-19 | Herabstufung | Argus | Buy → Hold |
| 2022-08-22 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-01-28 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2021-01-11 | Hochstufung | Argus | Hold → Buy |
| 2021-01-11 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2021-01-08 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-07-14 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-07-13 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Fortgesetzt | Deutsche Bank | Buy |
| 2020-05-15 | Hochstufung | Mizuho | Neutral → Buy |
| 2020-04-29 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-04-27 | Hochstufung | Citigroup | Neutral → Buy |
| 2020-04-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2019-07-16 | Hochstufung | BofA/Merrill | Underperform → Neutral |
| 2019-06-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-04-02 | Hochstufung | Jefferies | Hold → Buy |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2019-01-03 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-12-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2018-10-30 | Herabstufung | Argus | Buy → Hold |
| 2018-10-25 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2018-10-19 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-06-07 | Hochstufung | KeyBanc Capital Mkts | Sector Weight → Overweight |
| 2018-05-01 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2018-03-23 | Eingeleitet | Argus | Buy |
Alle ansehen
Labcorp Holdings Inc Aktie (LH) Neueste Nachrichten
Labcorp Denied Early Win In 401(k) Fee Suit - Law360
Is Labcorp Holdings Stock Outperforming the Nasdaq? - MSN
A Look Back at Testing & Diagnostics Services Stocks’ Q4 Earnings: Labcorp (NYSE:LH) Vs The Rest Of The Pack - Yahoo Finance
Labcorp to close Los Angeles site, lay off 73 people - Yahoo Finance
Why Labcorp (LH) is a Top Growth Stock for the Long-Term - Yahoo Finance
Labcorp Holdings Inc. (NYSE:LH) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed? - Simply Wall St
Labcorp is Set to Acquire Select Assets of BioReference Health of OPK - Yahoo Finance
Labcorp Warns Fed. Circ. Of 'Balkanization' In Prenatal IP Row - Law360
Labcorp’s SWOT analysis: clinical testing giant’s stock faces growth opportunities - Investing.com
Labcorp to acquire certain assets of Opko Health’s BioReference Health - Yahoo Finance
Truist remains bullish on Labcorp after ‘another nice strategic acquisition’ - Yahoo Finance
Labcorp to buy Opko unit’s cancer test assets for up to $225M - Yahoo Finance
Labcorp to acquire BioReference Health assets for up to $225M By Investing.com - Investing.com Canada
Truist maintains Buy on LabCorp stock, keeps $285 target By Investing.com - Investing.com Canada
Opko Health Sells BioReference Assets to Labcorp - TipRanks
Labcorp Announces Acquisition Of Select Assets Of Bioreference Health's Innovative Oncology And Related Clinical Testing Services Businesses - Marketscreener.com
Labcorp to buy certain assets of OPKO unit BioReference Health - MSN
Labcorp stock gains on deal to buy OPKO assets (LH:NYSE) - Seeking Alpha
Labcorp to Buy Some OPKO BioReference Assets for Up to $225 Million - MarketWatch
Labcorp To Buy Certain Assets Of BioReference Health For A Maximum $225 Mln - Nasdaq
Labcorp's $225M Oncology Testing Expansion: Strategic BioReference Assets Acquisition Promises Market Growth - StockTitan
Labcorp Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Labcorp Holdings' (NYSE:LH) Strong Earnings Are Of Good Quality - Yahoo Finance
Labcorp director Anderson sells shares for $127,817 By Investing.com - Investing.com Australia
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation - MSN
Labcorp director Anderson sells shares for $127,817 - Investing.com
Should Labcorp Stock Stay In Your Portfolio Right Now? - Barchart
Should Labcorp Stock Stay in Your Portfolio Right Now? - Nasdaq
Labcorp Faces Mixed Investor Reactions Amid Market FluctuationsNews and Statistics - IndexBox, Inc.
Citigroup Upgrades Labcorp Holdings (LH) - MSN
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed - MSN
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock By Investing.com - Investing.com South Africa
Labcorp’s EVP Mark Schroeder sells $1.33 million in stock - Investing.com India
Labcorp Holdings Insider Sold Shares Worth $1,330,639, According to a Recent SEC Filing - Marketscreener.com
What 10 Analyst Ratings Have To Say About Labcorp Hldgs - Benzinga
Citigroup Upgrades Labcorp Holdings to Buy From Neutral, Adjusts Price Target to $300 From $250 - Marketscreener.com
Fortrea Faces Spin-Related Challenges in the Near Term; Positive Long-Term Outlook - Morningstar
Is the Market Bullish or Bearish on Labcorp Hldgs? - Benzinga
Insider Sell: van der Vaart Sandra D Sells 1,314 Shares of Labco - GuruFocus.com
Labcorp Executive Cashes In on Stock Sale! - TipRanks
Labcorp Holdings EVP sells $330,208 in stock By Investing.com - Investing.com Australia
Labcorp Holdings EVP sells $330,208 in stock - Investing.com India
Finanzdaten der Labcorp Holdings Inc-Aktie (LH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.94%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):